347 related articles for article (PubMed ID: 33827675)
41. Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject.
Tiepolt S; Patt M; Hoffmann KT; Schroeter ML; Sabri O; Barthel H
J Alzheimers Dis; 2015; 47(3):539-43. PubMed ID: 26401690
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
43. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
[TBL] [Abstract][Full Text] [Related]
44. Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment.
Apostolova I; Lange C; Suppa P; Spies L; Klutmann S; Adam G; Grothe MJ; Buchert R;
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1417-1422. PubMed ID: 29502311
[TBL] [Abstract][Full Text] [Related]
45. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
Fujishiro H; Iseki E; Murayama N; Yamamoto R; Higashi S; Kasanuki K; Suzuki M; Arai H; Sato K
Psychogeriatrics; 2010 Sep; 10(3):144-52. PubMed ID: 20860570
[TBL] [Abstract][Full Text] [Related]
46. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
[TBL] [Abstract][Full Text] [Related]
47. A metabolism-functional connectome sparse coupling method to reveal imaging markers for Alzheimer's disease based on simultaneous PET/MRI scans.
Wang L; Xu H; Wang M; Brendel M; Rominger A; Shi K; Han Y; Jiang J
Hum Brain Mapp; 2023 Dec; 44(17):6020-6030. PubMed ID: 37740923
[TBL] [Abstract][Full Text] [Related]
48. Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease.
Bergeron D; Beauregard JM; Soucy JP; Verret L; Poulin S; Matias-Guiu JA; Cabrera-Martín MN; Bouchard RW; Laforce R
J Alzheimers Dis; 2020; 77(4):1569-1577. PubMed ID: 32925054
[TBL] [Abstract][Full Text] [Related]
49. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
[TBL] [Abstract][Full Text] [Related]
50. Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters.
Coutinho AM; Busatto GF; de Gobbi Porto FH; de Paula Faria D; Ono CR; Garcez AT; Squarzoni P; de Souza Duran FL; de Oliveira MO; Tres ES; Brucki SMD; Forlenza OV; Nitrini R; Buchpiguel CA
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2666-2680. PubMed ID: 32055966
[TBL] [Abstract][Full Text] [Related]
51. Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
Lee YH; Jeon S; Yoo HS; Chung SJ; Jung JH; Baik K; Sohn YH; Lee PH; Yun M; Evans AC; Ye BS
J Alzheimers Dis; 2021; 79(4):1471-1487. PubMed ID: 33459638
[TBL] [Abstract][Full Text] [Related]
52. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
Iizuka T; Kameyama M
Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
[TBL] [Abstract][Full Text] [Related]
53. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
[TBL] [Abstract][Full Text] [Related]
54. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages.
Brugnolo A; Orso B; Girtler N; Ferraro PM; Arnaldi D; Mattioli P; Massa F; Famà F; Argenti L; Biffa G; Morganti W; Buonopane S; Uccelli A; Morbelli S; Pardini M
Cortex; 2024 Feb; 171():413-422. PubMed ID: 38113612
[TBL] [Abstract][Full Text] [Related]
55. Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints.
Brugnolo A; Morbelli S; Arnaldi D; De Carli F; Accardo J; Bossert I; Dessi B; Famà F; Ferrara M; Girtler N; Picco A; Rodriguez G; Sambuceti G; Nobili F
J Alzheimers Dis; 2014; 39(1):103-13. PubMed ID: 24150105
[TBL] [Abstract][Full Text] [Related]
56. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S
Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787
[TBL] [Abstract][Full Text] [Related]
57. Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment.
Tondo G; Boccalini C; Vanoli EG; Presotto L; Muscio C; Ciullo V; Banaj N; Piras F; Filippini G; Tiraboschi P; Tagliavini F; Frisoni GB; Cappa SF; Spalletta G; Perani D;
Neurology; 2022 Jul; 99(3):e258-e269. PubMed ID: 35487700
[TBL] [Abstract][Full Text] [Related]
58. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of the posterior cingulate region with FDG-PET and advanced MR techniques in patients with amnestic mild cognitive impairment: comparison of the methods.
Zimny A; Bladowska J; Macioszek A; Szewczyk P; Trypka E; Wojtynska R; Noga L; Leszek J; Sasiadek M
J Alzheimers Dis; 2015; 44(1):329-38. PubMed ID: 24614904
[TBL] [Abstract][Full Text] [Related]
60. Effects of age on the glucose metabolic changes in mild cognitive impairment.
Kantarci K; Senjem ML; Lowe VJ; Wiste HJ; Weigand SD; Kemp BJ; Frank AR; Shiung MM; Boeve BF; Knopman DS; Petersen RC; Jack CR
AJNR Am J Neuroradiol; 2010 Aug; 31(7):1247-53. PubMed ID: 20299441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
